Company / Cost of Revenue
Bio-Techne Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$429.4M
FY2025
5-year range
$240.5M / $429.4M
FY2021-FY2025
Trend
+10.3%
vs FY2024
Sector context
#68 of 113
Health Care
What the data says
At $429M, Bio-Techne's cost of revenue ranks #46 of 113 in the Health Care sector. Cost of Revenue has increased for 4 consecutive years, from $241M in FY2021 to $429M in FY2025.
Based on SEC 10-K filings.
$429M in FY2025 with a 5-year CAGR of +10.9%.
Increased from $298M to $429M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +18.9%
- 5-Year CAGR
- +10.9%
- 10-Year CAGR
- -
Sector benchmark
#46 of 113 in Health CareTop 40% of 113This company $429.4M Sector average $11.3B
▼
-96.2% below sector average
Key checks
Key Insights
- Bio-Techne's cost of revenue has grown for 4 consecutive years.
- 5-year CAGR of +10.9%, indicating consistent growth.
- In FY2025, cost of revenue increased 10.3% year-over-year.
- Ranks #68 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $429.4M | +10.3% |
| FY2024 | $389.3M | +30.6% |
| FY2023 | $298.2M | +16.7% |
| FY2022 | $255.5M | +6.2% |
| FY2021 | $240.5M | -5.9% |
| FY2020 | $255.5M | +6.2% |
| FY2019 | $240.5M | +14.1% |
| FY2018 | $210.8M | +11.9% |
| FY2017 | $188.5M | +16.1% |
| FY2016 | $162.4M | +12.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026